We provide pharmacogenomic (PGx) and PCR-based molecular testing, plus blood and urine panels for disease management — led by a molecular pathologist and supported by clinical PharmD recommendations, from specimen to treatment plan.
Clinical PharmD Support
Medication & treatment guidance
Built Around Clinical Review
We review the clinical case before we run the test.
Before every molecular order, our team reviews clinical documentation to confirm clinical appropriateness — reducing payer declination and protecting your reimbursement. Testing proceeds only when the clinical case genuinely supports it, so nothing is run for its own sake.
This up-front review means fewer surprises for your practice and your patients. Claims are supported by the right documentation from the start, and providers get results they can act on without chasing paperwork after the fact — no back-and-forth with payers, no denials for missing justification, and no delays between the result and the decision it informs.
It also means the clinical case comes first. We only proceed when testing is genuinely warranted for the patient in front of you, so every result we return is one you ordered for a reason and can defend with confidence. That discipline protects your reimbursement, but more importantly it keeps the focus where it belongs — on the patient and the decision in front of you.
Every result is paired with physician-led interpretation and clinical pharmacist recommendations for medication selection, dosing, and treatment adjustments — giving providers a complete clinical picture, not just a lab value.
Our Tests
Fast and accurate results at your fingertips.
A physician-reviewed molecular test menu — with pre-authorization support and clinical PharmD recommendations at every step.
Most molecular test overreads are generated by software alone. Ours are reviewed by a physician.
Software-only interpretation
An algorithm returns a list.
Matches results against a database and returns a ranked list of options
No view of the patient's chart, medications, or diagnoses
Cannot account for interactions or clinical context
Limited documentation to support the clinical case
Consultative Genomics overread
A physician reviews the result.
Every result is overread by a trained molecular pathologist
Findings reviewed in the context of the patient's clinical information
Clear, clinically actionable interpretation and reporting
Documentation that supports the clinical case
Clinical PharmD recommendations accompany findings related to medications and treatment
Clinical Consultation
The interpretation comes with the test.
Request a consultation with your order and a molecular pathologist and clinical pharmacist review the result against your patient’s full picture — returning specific, patient-matched recommendations, not just a data point.
Physician overreads and PharmD recommendations on every result
Provider Support
Support at every step.
Molecular testing is most valuable when it is supported by clinical review and the right documentation. Our team works with providers to support appropriate clinical context, accurate documentation, and payer-ready requisitions.
Consultative Genomics is a great solution for providers who want quick, accurate results, and who want to give better, more personalized care to their patients.”
— Referring Provider, Houston, TX
We are here for you
Ready to get started?
Speak with an expert or explore our tests to bring fast, accurate molecular testing into your practice.
